Uptravi patent expiration date?

See the DrugPatentWatch profile for Uptravi

When Does Uptravi Patent Expiration Date?

The primary patent for Uptravi (selexipag) is set to expire in the United States in 2034 [1]. However, patent expiration dates can be complex and may vary by country [2].

What Happens After the Patent Expires?

Once patents expire, generic versions of a drug can potentially enter the market [3]. This often leads to increased competition and a decrease in drug prices [3].

Are There Other Patents or Exclusivities for Uptravi?

Drug patent landscapes can involve multiple patents, including method-of-use patents and formulation patents, which can extend market exclusivity beyond the expiration of the primary patent [2]. It is also possible for regulatory exclusivities, such as Orphan Drug Exclusivity or New Chemical Entity exclusivity, to be granted, providing additional periods of market protection [3]. For detailed information on specific patents and their expiration dates for Uptravi, DrugPatentWatch.com offers a comprehensive database [1].

Who Manufactures Uptravi?

Uptravi is manufactured by Actelion Pharmaceuticals Ltd. [1].